Research and development expenses of ¥51 million for the nine-month period ended the third quarter
First written in FY2017-Q3. 6 of 32 entries say "Restated". Latest entry: FY2026.
42 other companies' latest entry also says "Other".
- FY2026Lower full-year R&D expensesAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥74.385 million.」
Full-year R&D expenses were ¥74.385 million, down from ¥78.145 million in the previous fiscal year. - FY2026-H1Decrease in interim R&D expenseAnnual report
「Total R&D expenses for the current consolidated interim period were ¥37 million.」
R&D expenses for the interim period were ¥37 million, down from ¥40 million in the same period of the previous year. - FY2025-H1RestatedAnnual report
「Total R&D expenses for the current consolidated interim period were ¥40 million.」
R&D expenses for the interim period were ¥40 million, unchanged from ¥40 million in the same period of the previous year. - FY2025-Q1Slight decrease in first-quarter R&D expensesAnnual report
「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥20 million.」
R&D expenses for the first quarter were ¥20 million, a modest decrease from ¥21 million in the same period of the previous year. - FY2024-Q3Increase in R&D expenses for the first 3 quartersAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥61 million.」
Cumulative R&D expenses through the third quarter were ¥61 million, up from ¥58 million in the same period of the previous year. - FY2024-Q2Slight decrease in second-quarter R&D expensesAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥40 million.」
Cumulative R&D expenses through the second quarter were ¥40 million, a modest decrease from ¥41 million in the same period of the previous year. - FY2024-Q1Slight decrease in first-quarter R&D expensesAnnual report
「Total research and development expenses for the first quarter of the current consolidated fiscal year were ¥21 million.」
R&D expenses for the first quarter were ¥21 million, a modest decrease from ¥22 million in the same period of the previous year. - FY2023-Q3Decrease in third-quarter R&D expensesAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥58 million.」
Cumulative R&D expenses through the third quarter were ¥58 million, down from ¥61 million in the same period of the previous year. - FY2023-Q2Slight decrease in second-quarter R&D expensesAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥40 million.」
Cumulative R&D expenses through the second quarter were ¥40 million, a modest decrease from ¥41 million in the same period of the previous year. - FY2023-Q1First-quarter R&D expenditure declinedAnnual report
「Total research and development expenses for the first quarter of the current consolidated fiscal year were ¥21 million.」
R&D expenses for the first quarter were ¥21 million, down from ¥22 million in the same period of the previous year. - FY2022Increase in full-year R&D expensesAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥80.079 million.」
Full-year R&D expenses were ¥80.079 million, up from ¥69.835 million in the previous fiscal year. - FY2022-Q3Increase in R&D expenses for the first 3 quartersAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥61 million.」
Cumulative R&D expenses through the third quarter were ¥61 million, up from ¥53 million in the same period of the previous year. - FY2022-Q2Increase in second-quarter R&D expensesAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥41 million.」
Cumulative R&D expenses through the second quarter were ¥41 million, up from ¥37 million in the same period of the previous year. - FY2022-Q1Increase in first-quarter research and development expensesAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥22 million.」
R&D expenses were ¥22 million, up from ¥19 million in the same period of the previous year. - FY2021Increase in full-year R&D expensesAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥69.835 million.」
Full-year R&D expenses were ¥69.835 million, up from ¥66.694 million in the previous fiscal year. - FY2021-Q3Slight increase in third-quarter R&D expensesAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥53 million.」
Cumulative R&D expenses through the third quarter were ¥53 million, a slight increase from ¥52 million in the same period of the previous year. - FY2021-Q2Second-quarter R&D expenses decreasedAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥37 million.」
Cumulative R&D expenses through the second quarter were ¥37 million, down from ¥42 million in the same period of the previous year. - FY2021-Q1Increase in first-quarter research and development expensesAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥19 million.」
R&D expenses for the first quarter were ¥19 million, up from ¥16 million in the same period of the previous year. - FY2020Lower full-year R&D expensesAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥66.694 million.」
Full-year R&D expenses were ¥66.694 million, down from ¥74.459 million in the previous fiscal year. - FY2020-Q3Decrease in third-quarter R&D expensesAnnual report
「Total research and development expense for the cumulative third quarter of the current consolidated fiscal year was ¥52 million.」
Cumulative R&D expenses through the third quarter were ¥52 million, down from ¥57 million in the same period of the previous year. - FY2020-Q2Second-quarter R&D expenses decreasedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥33 million.」
Cumulative R&D expenses through the second quarter were ¥33 million, down from ¥42 million in the same period of the previous year. - FY2020-Q1First-quarter R&D expenditure declinedAnnual report
「Total R&D expenses for the current consolidated cumulative period were ¥16 million.」
R&D expenses for the first quarter were ¥16 million, down from ¥20 million in the same period of the previous year. - FY2019Increase in full-year R&D expensesAnnual report
「As a result of these activities, total research and development expenses for the fiscal year were ¥74.459 million.」
Full-year research and development expenses were ¥74.459 million, up from ¥67.921 million in the previous fiscal year. - FY2019-Q3Increase in R&D ExpensesAnnual report
「Total research and development expenses for the nine months ended Q3 were ¥57 million.」
Research and development expenses increased from ¥51 million in the same period of the previous year to ¥57 million. - FY2019-Q2Continued increase in R&D expensesAnnual report
「Total research and development expenses for the six months ended Q2 were ¥42 million.」
Research and development expenses increased from ¥34 million in the same period of the previous year to ¥42 million, continuing the upward trend through the previous quarter. - FY2019-Q1Increase in R&D ExpensesAnnual report
「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥20 million.」
Research and development expenses for Q1 were ¥20 million, up from ¥17 million in the same period of the previous year. - FY2018RestatedAnnual report
「As a result of these activities, total research and development expenses for the fiscal year were ¥67.921 million.」
The Company disclosed full-year research and development expenses of ¥67.921 million. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the nine months ended Q3 were ¥51 million.」
The Company again disclosed total research and development expenses of ¥51 million for the nine months ended Q3. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the six months ended Q2 were ¥34 million.」
The Company disclosed total research and development expenses of ¥34 million for the six months ended Q2. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥17 million.」
The Company disclosed total research and development expenses of ¥17 million for the three months ended Q1. - FY2017RestatedAnnual report
「As a result of these activities, total research and development expenses for the fiscal year were ¥68.529 million.」
Following ¥51 million for the nine months ended Q3, the Company disclosed full-year research and development expenses of ¥68.529 million. - FY2017-Q3First statedAnnual report
「Total research and development expenses for the nine months ended Q3 were ¥51 million.」
The Company disclosed total research and development expenses of ¥51 million for the nine months ended Q3.